The protective effect of ACEIs in patients with prostate cancer has been suggested to possibly be linked to increased levels of renin and Ag-I, with subsequent downstream effects on bradykinin and prostaglandins, whilst potentially reducing Ag-II. This evidence concerns the gene REN and Familial prostate cancer.